SEC Form 4 · accession 0001127602-18-009477
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman & CEO · Director
Period of report
Feb 28, 2018
Accepted (ET)
Mar 2, 2018 · 7:34 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 28, 2018 | S | 60 | $108.335 | D | 305,982 | D | |
| Common Stock | Feb 28, 2018 | S | 500 | $108.34 | D | 305,482 | D | |
| Common Stock | Feb 28, 2018 | S | 100 | $108.35 | D | 305,382 | D | |
| Common Stock | Feb 28, 2018 | S | 40 | $108.365 | D | 305,342 | D | |
| Common Stock | Feb 28, 2018 | S | 400 | $108.37 | D | 304,942 | D | |
| Common Stock | Feb 28, 2018 | S | 200 | $108.44 | D | 304,742 | D | |
| Common Stock | Feb 28, 2018 | S | 100 | $108.53 | D | 304,642 | D | |
| Common Stock | Feb 28, 2018 | S | 202 | $108.54 | D | 304,440 | D | |
| Common Stock | Feb 28, 2018 | S | 100 | $108.635 | D | 304,340 | D | |
| Common Stock | Feb 28, 2018 | S | 200 | $108.64 | D | 304,140 | D | |
| Common Stock | Feb 28, 2018 | S | 200 | $108.75 | D | 303,940 | D | |
| Common Stock | Feb 28, 2018 | F | 2,264 | $107.82 | D | 301,676 | D | |
| Common Stock | holding | — | — | — | 10,208 | I | 2016 GRAT | |
| Common Stock | holding | — | — | — | 29,954 | I | 2017 GRAT | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.